Global Asthma and COPD Drugs Market Professional Survey Report 2018 - 2025

Description

This report studies the global Asthma and COPD Drugs market status and forecast, categorizes the global Asthma and COPD Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Asthma is a chronic respiratory disease blocking the airways of lung because of inflammation, mucus production, tighten of muscles. Chronic Obstructive Pulmonary Disease(COPD) is caused by obstruction in the airways causing difficulty in breathing, with the primary cause as tobacco smoking.
The Global Asthma and COPD Drugs market is segmented based on disease, medication class and geography. Based on disease, the market is categorized into asthma and COPD.
The global Asthma and COPD Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
GlaxoSmithKline
Novartis
Merck
Abbott Laboratories
Boehringer Ingelheim
AstraZeneca
Roche Holding AG
Teva Pharmaceutical Industries
Vectura Group
Pfizer

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
COPD
Asthma

By Application, the market can be split into
Combination Products
Leukotriene Antagonists (LTA)
Inhaled Corticosteroids (ICS)
Anticholinergics
Short Acting Beta Agonists(SABA)
Long Acting Beta Agonists (LABA)
Others

The study objectives of this report are:
To analyze and study the global Asthma and COPD Drugs capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Asthma and COPD Drugs manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Asthma and COPD Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Asthma and COPD Drugs Manufacturers
Asthma and COPD Drugs Distributors/Traders/Wholesalers
Asthma and COPD Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, We offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Asthma and COPD Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

TABLE OF CONTENT

Table of Contents

Global Asthma and COPD Drugs Market Professional Survey Report 2018
1 Industry Overview of Asthma and COPD Drugs
1.1 Definition and Specifications of Asthma and COPD Drugs
1.1.1 Definition of Asthma and COPD Drugs
1.1.2 Specifications of Asthma and COPD Drugs
1.2 Classification of Asthma and COPD Drugs
1.2.1 COPD
1.2.2 Asthma
1.3 Applications of Asthma and COPD Drugs
1.3.1 Combination Products
1.3.2 Leukotriene Antagonists (LTA)
1.3.3 Inhaled Corticosteroids (ICS)
1.3.4 Anticholinergics
1.3.5 Short Acting Beta Agonists(SABA)
1.3.6 Long Acting Beta Agonists (LABA)
1.3.7 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of Asthma and COPD Drugs
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Asthma and COPD Drugs
2.3 Manufacturing Process Analysis of Asthma and COPD Drugs
2.4 Industry Chain Structure of Asthma and COPD Drugs

3 Technical Data and Manufacturing Plants Analysis of Asthma and COPD Drugs
3.1 Capacity and Commercial Production Date of Global Asthma and COPD Drugs Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Asthma and COPD Drugs Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Asthma and COPD Drugs Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Asthma and COPD Drugs Major Manufacturers in 2017

4 Global Asthma and COPD Drugs Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Asthma and COPD Drugs Capacity and Growth Rate Analysis
4.2.2 2017 Asthma and COPD Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Asthma and COPD Drugs Sales and Growth Rate Analysis
4.3.2 2017 Asthma and COPD Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Asthma and COPD Drugs Sales Price
4.4.2 2017 Asthma and COPD Drugs Sales Price Analysis (Company Segment)

5 Asthma and COPD Drugs Regional Market Analysis
5.1 North America Asthma and COPD Drugs Market Analysis
5.1.1 North America Asthma and COPD Drugs Market Overview
5.1.2 North America 2013-2018E Asthma and COPD Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Asthma and COPD Drugs Sales Price Analysis
5.1.4 North America 2017 Asthma and COPD Drugs Market Share Analysis
5.2 Europe Asthma and COPD Drugs Market Analysis
5.2.1 Europe Asthma and COPD Drugs Market Overview
5.2.2 Europe 2013-2018E Asthma and COPD Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Asthma and COPD Drugs Sales Price Analysis
5.2.4 Europe 2017 Asthma and COPD Drugs Market Share Analysis
5.3 China Asthma and COPD Drugs Market Analysis
5.3.1 China Asthma and COPD Drugs Market Overview
5.3.2 China 2013-2018E Asthma and COPD Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Asthma and COPD Drugs Sales Price Analysis
5.3.4 China 2017 Asthma and COPD Drugs Market Share Analysis
5.4 Japan Asthma and COPD Drugs Market Analysis
5.4.1 Japan Asthma and COPD Drugs Market Overview
5.4.2 Japan 2013-2018E Asthma and COPD Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Asthma and COPD Drugs Sales Price Analysis
5.4.4 Japan 2017 Asthma and COPD Drugs Market Share Analysis
5.5 Southeast Asia Asthma and COPD Drugs Market Analysis
5.5.1 Southeast Asia Asthma and COPD Drugs Market Overview
5.5.2 Southeast Asia 2013-2018E Asthma and COPD Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Asthma and COPD Drugs Sales Price Analysis
5.5.4 Southeast Asia 2017 Asthma and COPD Drugs Market Share Analysis
5.6 India Asthma and COPD Drugs Market Analysis
5.6.1 India Asthma and COPD Drugs Market Overview
5.6.2 India 2013-2018E Asthma and COPD Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Asthma and COPD Drugs Sales Price Analysis
5.6.4 India 2017 Asthma and COPD Drugs Market Share Analysis

6 Global 2013-2018E Asthma and COPD Drugs Segment Market Analysis (by Type)
6.1 Global 2013-2018E Asthma and COPD Drugs Sales by Type
6.2 Different Types of Asthma and COPD Drugs Product Interview Price Analysis
6.3 Different Types of Asthma and COPD Drugs Product Driving Factors Analysis
6.3.1 COPD Growth Driving Factor Analysis
6.3.2 Asthma Growth Driving Factor Analysis

7 Global 2013-2018E Asthma and COPD Drugs Segment Market Analysis (by Application)
7.1 Global 2013-2018E Asthma and COPD Drugs Consumption by Application
7.2 Different Application of Asthma and COPD Drugs Product Interview Price Analysis
7.3 Different Application of Asthma and COPD Drugs Product Driving Factors Analysis
7.3.1 Combination Products of Asthma and COPD Drugs Growth Driving Factor Analysis
7.3.2 Leukotriene Antagonists (LTA) of Asthma and COPD Drugs Growth Driving Factor Analysis
7.3.3 Inhaled Corticosteroids (ICS) of Asthma and COPD Drugs Growth Driving Factor Analysis
7.3.4 Anticholinergics of Asthma and COPD Drugs Growth Driving Factor Analysis
7.3.5 Short Acting Beta Agonists(SABA) of Asthma and COPD Drugs Growth Driving Factor Analysis
7.3.6 Long Acting Beta Agonists (LABA) of Asthma and COPD Drugs Growth Driving Factor Analysis
7.3.7 Others of Asthma and COPD Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Asthma and COPD Drugs
8.1 GlaxoSmithKline
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 GlaxoSmithKline 2017 Asthma and COPD Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 GlaxoSmithKline 2017 Asthma and COPD Drugs Business Region Distribution Analysis
8.2 Novartis
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Novartis 2017 Asthma and COPD Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Novartis 2017 Asthma and COPD Drugs Business Region Distribution Analysis
8.3 Merck
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Merck 2017 Asthma and COPD Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Merck 2017 Asthma and COPD Drugs Business Region Distribution Analysis
8.4 Abbott Laboratories
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Abbott Laboratories 2017 Asthma and COPD Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Abbott Laboratories 2017 Asthma and COPD Drugs Business Region Distribution Analysis
8.5 Boehringer Ingelheim
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Boehringer Ingelheim 2017 Asthma and COPD Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Boehringer Ingelheim 2017 Asthma and COPD Drugs Business Region Distribution Analysis
8.6 AstraZeneca
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 AstraZeneca 2017 Asthma and COPD Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 AstraZeneca 2017 Asthma and COPD Drugs Business Region Distribution Analysis
8.7 Roche Holding AG
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Roche Holding AG 2017 Asthma and COPD Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Roche Holding AG 2017 Asthma and COPD Drugs Business Region Distribution Analysis
8.8 Teva Pharmaceutical Industries
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Teva Pharmaceutical Industries 2017 Asthma and COPD Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Teva Pharmaceutical Industries 2017 Asthma and COPD Drugs Business Region Distribution Analysis
8.9 Vectura Group
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Vectura Group 2017 Asthma and COPD Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Vectura Group 2017 Asthma and COPD Drugs Business Region Distribution Analysis
8.10 Pfizer
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Pfizer 2017 Asthma and COPD Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Pfizer 2017 Asthma and COPD Drugs Business Region Distribution Analysis

9 Development Trend of Analysis of Asthma and COPD Drugs Market
9.1 Global Asthma and COPD Drugs Market Trend Analysis
9.1.1 Global 2018-2025 Asthma and COPD Drugs Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Asthma and COPD Drugs Sales Price Forecast
9.2 Asthma and COPD Drugs Regional Market Trend
9.2.1 North America 2018-2025 Asthma and COPD Drugs Consumption Forecast
9.2.2 Europe 2018-2025 Asthma and COPD Drugs Consumption Forecast
9.2.3 China 2018-2025 Asthma and COPD Drugs Consumption Forecast
9.2.4 Japan 2018-2025 Asthma and COPD Drugs Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Asthma and COPD Drugs Consumption Forecast
9.2.6 India 2018-2025 Asthma and COPD Drugs Consumption Forecast
9.3 Asthma and COPD Drugs Market Trend (Product Type)
9.4 Asthma and COPD Drugs Market Trend (Application)

10 Asthma and COPD Drugs Marketing Type Analysis
10.1 Asthma and COPD Drugs Regional Marketing Type Analysis
10.2 Asthma and COPD Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Asthma and COPD Drugs by Region
10.4 Asthma and COPD Drugs Supply Chain Analysis

11 Consumers Analysis of Asthma and COPD Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Asthma and COPD Drugs Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source

Choose License Type

Checkout Inquiry